Brokers Set Expectations for ESPR Q1 Earnings
Esperion Therapeutics, Inc. (NASDAQ:ESPR – Free Report) – Equities researchers at HC Wainwright issued their Q1 2025 earnings per share estimates for shares of Esperion Therapeutics in a research note issued to investors on Tuesday, March 4th. HC Wainwright analyst J. Pantginis anticipates that the biopharmaceutical company will post earnings per share of ($0.16) for […]
Esperion Therapeutics, Inc. (NASDAQ:ESPR – Free Report) – Equities researchers at HC Wainwright issued their Q1 2025 earnings per share estimates for shares of Esperion Therapeutics in a research note issued to investors on Tuesday, March 4th. HC Wainwright analyst J. Pantginis anticipates that the biopharmaceutical company will post earnings per share of ($0.16) for […]
